PATENT CLAIM ANALYSIS

Application Number: 15994887
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-05
Patent Classification: ["424", "204100"]

Abstract:
The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.

Claim (Index 12):
The method of  claim 11 , wherein said toll-like receptor agonist is monophosphoryl lipid A (MPL).

Metadata:
- Claim Count in Document: 26.0
- Percentile: 93.0
- Lexical Diversity: 1.54286
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13836446', '12816495', '13837653', '12093921', '13837885']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8724572933960167
- 35 USC 102 Novelty (BERT): 0.6227820849828486
- Combined Prediction Score: 0.8474897725546999
- Mean Citation Score: 692.884718
- Max Citation Score: 705.352
- Similarity Product: 486.1375421667098

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test